2-Methoxylated FA Display Unusual Antibacterial Activity Towards Clinical Isolates of Methicillin-Resistant Staphylococcus aureus (CIMRSA) and Escherichia coli

Lipids
Néstor M CarballeiraDavid J Sanabria-Ríos

Abstract

The naturally occurring (6Z)-(±)-2-methoxy-6-hexadecenoic acid (1) and (6Z)-(±)-2-methoxy-6-octadecenoic acid (2) were synthesized in 7-8 steps with 38 and 13% overall yields, respectively, by using an acetylide coupling approach, which made it possible to obtain a 100% cis-stereochemistry for the double bonds. In a similar fashion, the acetylenic analogs (±)-2-methoxy-6-hexadecynoic acid (3) and (±)-2-methoxy-6-octadecynoic acid (4) were also synthesized in 6-7 steps with 48 and 16% overall yields, respectively. The antibacterial activity of acids 1-4 was determined against clinical isolates of methicillin-resistant Staphylococcus aureus (ClMRSA) and Escherichia coli. Among the series of compounds, acid 4 was the most active bactericide towards CIMRSA displaying IC50s (half maximal inhibitory concentrations) between 17 and 37 μg/mL, in sharp contrast to the 6-octadecynoic acid, which was not bactericidal at all. On the other hand, acids 1 and 3 were the only acids that displayed antibacterial activity towards E. coli, but 1 stood out as the best candidate with an IC50 of 21 μg/mL. The critical micelle concentrations (CMCs) of acids 1-4 were also determined. The C18 acids 2 and 4 displayed a five-fold lower CMC (15-20 μg/mL) th...Continue Reading

References

Aug 28, 1990·Biochimica Et Biophysica Acta·P N Black
Jul 1, 1986·The Journal of Infectious Diseases·H R Knapp, M A Melly
Dec 1, 1973·The Journal of Applied Bacteriology·H Galbraith, T B Miller
Jul 9, 1999·Progress in Lipid Research·C C DiRussoJ D Weimar
Apr 11, 2002·Lipids·Néstor M Carballeira, Johanna Alicea
Aug 10, 2002·Progress in Lipid Research·N M Carballeira
Mar 24, 2004·Archiv der Pharmazie·Néstor M CarballeiraSoroush Sardari
Dec 14, 2004·Lipids·Néstor M CarballeiraScott Franzblau
Jul 12, 2005·Current Opinion in Structural Biology·Bert van den Berg
Dec 4, 2009·Applied Microbiology and Biotechnology·Andrew P Desbois, Valerie J Smith
Feb 18, 2010·Tetrahedron Letters·Néstor M CarballeiraKeykavous Parang
May 8, 2013·Chemistry and Physics of Lipids·Elsie A OrellanoNéstor M Carballeira
Dec 25, 2013·Chemistry and Physics of Lipids·David J Sanabria-RíosNéstor M Carballeira
Apr 9, 2014·Antimicrobial Agents and Chemotherapy·Michaël L CartronSimon J Foster
Oct 21, 2015·Bioorganic & Medicinal Chemistry Letters·David J Sanabria-RíosNéstor M Carballeira

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.